LINNIK MATTHEW D 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Sep 19, 2003
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Award
Stock Options (right to buy)
2003-09-18$4.71/sh+60,338$284,192→ 669,000 totalExercise: $4.71Exp: 2013-09-18→ Common Stock (60,338 underlying) - Other
Common Stock
2003-06-30$1.48/sh+498$737→ 1,825 total - Award
Stock Options (right to buy)
2003-09-18$4.71/sh+14,662$69,058→ 608,662 totalExercise: $4.71Exp: 2013-09-18→ Common Stock (14,662 underlying)
Footnotes (2)
- [F1]Acquired pursuant to the Company???s Employee Stock Purchase Plan.
- [F2]The stock options vest and become exercisable monthly over the next three years.